Zoledronic Acid Monohydrate News
Zoledronic Acid Monohydrate currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Zoledronic Acid Monohydrate with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies...
- Evidence level: L5
- Predicted indications (20):
- bone Paget disease (99.6%)
- HIV infectious disease (94.0%)
- obsolete familial combined hyperlipidemia (93.5%)
- neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter (93.1%)
- biotin metabolic disease (92.9%)
- feline acquired immunodeficiency syndrome (91.0%)
- simian immunodeficiency virus infection (91.0%)
- vitamin deficiency disorder (90.3%)
- postmenopausal osteoporosis (90.1%)
- Worth syndrome (89.9%)
- succinyl-CoA:3-ketoacid CoA transferase deficiency (89.8%)
- autosomal dominant neovascular inflammatory vitreoretinopathy (89.3%)
- hypoglycemia (89.2%)
- pregnancy associated osteoporosis (88.2%)
- juvenile Paget disease (87.7%)
- cholelithiasis (85.6%)
- osteomesopyknosis (83.6%)
- Paget disease of bone (83.3%)
- palmar fibromatosis (79.8%)
- homozygous familial hypercholesterolemia (79.5%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.